INTRODUCTION
Genes contributing to embryonic development are frequently involved in multiple processes. This pleiotropy is associated with elaborated gene expression profiles established by specialized cis-regulatory modules, each one dedicated to a subset of the overall expression pattern. In vertebrates, these regulatory sequences can be remarkably far from the promoter region of their target genes (Carvajal et al., 2001; Lettice et al., 2003; Spitz et al., 2003; Zuniga et al., 2004; Kleinjan et al., 2006) . Large-scale screens for sequences with regulatory activities revealed many enhancers far from genes (Pennacchio et al., 2006; Visel et al., 2009; Sanyal et al., 2012; Shen et al., 2012) , implying further that long-range regulatory elements exert a prevalent influence on gene expression. In several instances, remote enhancers have been shown to act not only on their biologically relevant targets, but as well on neighboring ''bystander'' genes (Spitz et al., 2003; Cajiao et al., 2004; Zuniga et al., 2004) , suggesting that many enhancers may have no intrinsic target specificity. However, in many other loci, adjacent genes appear to be regulated independently, implying that regulatory mechanisms must exist that ensure specificity of functional long-range enhancerpromoter interactions.
Studies of genes regulated by long-range enhancers have been instrumental in understanding the mechanisms that influence enhancer-promoter interactions. Some enhancers preferentially interact with promoters with specific elements, such as either TATA boxes or downstream promoter elements (DPEs) (Ohtsuki et al., 1998; Butler and Kadonaga, 2001) . Other promoter-proximal sequences acting as ''tethering elements'' may help securing interactions with specific enhancers (Calhoun et al., 2002) . Insulator elements with enhancer-blocking activity can also prevent ectopic interactions between enhancers and neighboring genes (Chung et al., 1993; Tanimoto et al., 1999; Murrell et al., 2004) . These effects have been proposed to be mediated by protein complexes comprising CCCTC-binding factor (CTCF) and cohesins, which can promote formation of large chromatin loops to bring closer or keep separated promoters and remote regulatory elements (reviewed in Phillips and Corces, 2009; Dorsett, 2011) . It is noteworthy that these models are based on detailed and functional studies that have been carried out on a very small number of loci, often with peculiar structural characteristics: Hox and b-globin multigenic clusters (Palstra et al., 2008; Spitz and Duboule, 2008) , imprinted regions (Edwards and Ferguson-Smith, 2007) , or large gene deserts (Kokubu et al., 2009) . Knowing how enhancer activities are conveyed to their target genes in more typical loci should provide additional important insights into the underlying mechanisms.
Fibroblast growth factor 8 (Fgf8) is expressed during embryogenesis in highly restricted domains from where it directs the formation, growth, and patterning of many organs and structures, including brain, craniofacial skeleton, limbs, and kidneys among many others (Crossley and Martin, 1995; Martinez et al., 1999; Moon and Capecchi, 2000; Macatee et al., 2003; Grieshammer et al., 2005) . Many of the effects driven by Fgf8 are dose-dependent (Jaskoll et al., 2004; Storm et al., 2006) , implying that not only its spatial distribution but also its expression levels have to be tightly controlled during embryogenesis. Yet, only a handful of potential Fgf8 cis-regulatory elements have been identified so far (Hu et al., 2004; Beermann et al., 2006; Komisarczuk et al., 2009) . In contrast to other developmental genes with similarly complex expression patterns, Fgf8 lies in a relatively gene-dense region (Figure 1 ). This 0.6 Mb interval contains seven other protein-coding genes: two transcription factors (Tlx1, Lbx1) involved in spleen and limb muscle development, respectively (Roberts et al., 1994; Gross et al., 2000) , two F-box/WD-repeat proteins (Btrc, Fbxw4) (Hatakeyama et al., 1999; Sidow et al., 1999) , a DNA polymerase (Poll) (Bertocci et al., 2002) , a member of the nucleoplasmin/ nucleophosmin family of nuclear chaperones (Npm3) (MacArthur and Shackleford, 1997), and an uncharacterized protein (Dpcd) (Zariwala et al., 2004) . Interestingly, this neighborhood has been largely conserved during evolution (Wotton et al., 2008) , raising the possibility that regulatory elements contributing to Fgf8 expression may be localized at a distance, intertwined with the flanking genes. Thus, this region provides an ideal system to study the mechanisms of enhancer-to-gene specificity. Figure S1 for qPCR data. (B) Organization of the 600 kb-large locus extending from TLX1 to NPM3. Gene bodies are depicted as gray bars, with black ones representing exons. Centromeric (CEN) and telomeric (TEL) ends and the scale are indicated. A gray square bracket indicates the centromeric end of the BAC used in Beermann et al. (2006) . (C) Enhancer activity of individual CNEs from the BTRC-FGF8 interval. Genes are shown as gray rectangles, blue ovals depict CNEs with enhancer activity, and white ovals show tested CNEs that did not show any reproducible expression pattern. CNEs 81 and 83 (light blue) were described previously (Beermann et al., 2006) . For each enhancer element, a picture of a representative embryo is shown. See also Tables S1 and S2, and Figures 2 and S2 for additional information.
Here, we report an extensive study of the regulatory architecture of this region. With a variety of transgenic approaches and targeted rearrangements of the endogenous locus, we show that this region behaves as an integrated unit, a holo-enhancer: the internal organization of this intricate 200 kb interval has in itself an important role in integrating and filtering the activities of the multiple regulatory modules present within into a restricted tissue-and gene-specific output. We discuss the differences of this regulatory system compared to previously proposed models and how its characteristics can contribute to evolution of gene expression and account for the phenotypic consequences of genomic structural variants found in humans.
RESULTS
The Genes Flanking Fgf8 Are Independently Regulated We investigated the expression patterns of the different genes present next to Fgf8 in embryonic stage (E) 10.5 mouse embryos. Although whole-mount in situ hybridization revealed the highly patterned and restricted expression of Fgf8 in these embryos, its neighbors showed rather ubiquitous signals ( Figure 1A) , and we detected their expression in all tissues tested by RT-qPCR (Figure S1 available online). This basal, ubiquitous expression suggested that these genes were mostly unresponsive to the cis-regulatory elements that control Fgf8 expression.
Comprehensive Identification of Enhancers in the Lbx1-Fgf8
Interval Previous studies showed that a bacterial artificial chromosome (BAC) extending from 55 kb centromeric to 120 kb telomeric to the mouse Fgf8 gene failed to fully rescue the multiple defects caused by a mutation of Fgf8 (Beermann et al., 2006) . This suggested that sequences lying elsewhere were required to drive Fgf8, notably in the limbs and cranio-facial region. As sequence conservation is usually a good predictor of developmental enhancers, we considered noncoding evolutionary conserved elements (length > 200 bp, PhastCons score > 500) in the Lbx1-Fgf8 region (see Table S1 for details). We found that BACs centromeric to Fgf8 recapitulated its expression pattern in E10.5 embryos (see below), and therefore focused on this 200 kb region. We tested 48 elements for enhancer activity, representing collectively more than 20% of the length of the region, including all the nongenic elements conserved among mammals found between the 3 0 end of Btrc and Fgf8. Each element was cloned upstream of a LacZ reporter gene driven by a fragment of the human b-globin promoter region (À37 to +12) (Yee and Rigby, 1993) : this minimal promoter is not active by itself but has been shown to faithfully report the activity of a large variety of developmental enhancers (Jeong et al., 2006; Gonzalez et al., 2007) and can be activated in most tissues and embryonic structures (Ruf et al., 2011) .
We found that a majority of these elements conferred reproducible and specific expression patterns to the reporter gene in transgenic E10.5 embryos (Figures 1, 2, and S2; Table S2 ). Several of these patterns overlapped with known Fgf8 expression domains suggesting that the corresponding enhancers may contribute to Fgf8 expression. The majority of these enhancers were active in one or two domains only, revealing the extreme modular nature of Fgf8 regulation. Collectively, these enhancers cover most of the known Fgf8 domains of expression, with the notable exception of the ectoderm of the branchial arches. Available chromatin immunoprecipitation (ChIP) data for enhancer-associated marks (p300, H3K27ac) performed on embryos at comparable stages (Visel et al., 2009; Blow et al., 2010; Cotney et al., 2012) correlated relatively well with our transgenic activities (Table S2 ). Yet, many of the enhancers we found were not identified by these ChIP experiments, further suggesting that ChIP profiles for these marks may not offer a complete representation of the enhancers active in a given tissue (He et al., 2011) , likely due to a reduced power to detect elements active in only a subset of the cells from the tissue analyzed.
Interestingly, we found multiple elements with overlapping activities for almost each Fgf8-expressing region (Figures 2 and S2; Table S2 ). For example, CE79, like its zebrafish ortholog (Inoue et al., 2006) , drove expression in a narrow region corresponding to the midbrain-hindbrain boundary (MHB). However, we found two additional MHB enhancers (CE80, proximal to Fgf8, and CE64, distal and inside an intron of Fbxw4), each of them driving expression in a broader domain (Figures 2 and S2). The limb apical ectodermal ridge (AER) was characterized by an unexpected regulatory complexity, with at least five distinct enhancers being autonomously active in this domain (CE58, CE59, CE61, CE66, and CE80).
Distal Elements within Fbxw4 Control Fgf8 Expression
Many of these enhancer elements were found far from Fgf8, in introns of Fbxw4 or beyond. To determine if these elements contribute to Fgf8 expression, we engineered the deletion DEL(P-F4) by in vivo Cre-mediated recombination between loxP sites targeted to the Poll and Fbxw4 genes ( Figure 3A Figure S2 and Table S2. 1999; Bertocci et al., 2002) , but a deletion of Dpcd leads to hydrocephalus and situs inversus in mice (Kobayashi et al., 2002; Vogel et al., 2010) . The DEL(P-F4) deletion also includes enhancers CE58 to CE71. To look at their role regarding Fgf8 expression, we crossed males heterozygous for DEL(P-F4) with Fgf8 null/+ females. DEL(P-F4)/Fgf8 null animals retain functional copies of Fbxw4, Poll, and Dpcd (from the Fgf8 null chromosome) but the functional Fgf8 allele lacks the input provided in cis by the enhancers located in the deleted region, including four of the five AER enhancers, the three kidney enhancers and a broad MHB enhancer. Proximal enhancers (up to 90 kb from the Fgf8 promoter) were not affected, notably the MHB enhancer CE79 and the proximal AER/tail bud enhancer CE80. DEL(P-F4)/ Fgf8 null embryos were found alive at stage E18.5, however, not in Mendelian proportions ($50% of the expected number).
These embryos displayed developmental malformations and defects in many tissues known to be Fgf8-dependent, including strong craniofacial defects, kidney agenesis, deletion of midbrain/cerebellum structures, and absence of olfactory bulbs (Figures 3B, S3B, and S3C) resembling those described in strong Fgf8 hypomorphs (Meyers et al., 1998) . The aplasia of fore-and hindlimbs observed in DEL(P-F4)/Fgf8 null was similar to the one obtained upon limb-specific inactivation of Fgf8 (Lewandoski et al., 2000; Moon and Capecchi, 2000) , and more severe than the one seen in hypomorphic alleles (Meyers et al., 1998) .
We next examined embryos at earlier stages. At E9.5-10.5, compound heterozygous for DEL(P-F4) and (11/48 and 10/40, respectively). DEL(P-F4)/Fgf8 null and DEL(P-F4)/DEL(P-F8) embryos were phenotypically similar: they showed developmental delay, smaller limbs, and malformed brains compared to wild-type or heterozygous littermates (Figure 3C;  data not shown). They resembled the phenotypic group 1 in the Fgf8 hypomorph series analyzed by Meyers et al. (1998) .
To analyze Fgf8 expression from the DEL(P-F4) allele, we used compound embryos with the DEL(P-F8) allele, which lacked sequences used for the Fgf8 in situ probe. We failed to detect Fgf8 expression in DEL(P-F4)/DEL(P-F8) embryos at E9.5-10.5 by whole-mount in situ hybridization, contrarily to wild-type or DEL(P-F8)/+ controls ( Figures 3C and S3 ; data not shown). Importantly, expression was lost in domains for which some of the proximally located enhancers were still present (e.g., CE79 and CE80 for MHB, CE80 for AER), showing that these proximal elements were not sufficient to initiate or maintain Fgf8 expression in their domains of activity. In contrast, the analysis of a deletion removing 320 kb located between Lbx1 and Poll (DEL(L-P)) showed that it does not contain critical elements related to Fgf8 ( Figure S3E ).
Altogether, this genetic analysis showed that the distal enhancers we identified within Fbxw4 and around Poll-Dpcd are allelic to Fgf8 and control important aspects of its tissuespecific expression in midgestation embryos, whereas elements centromeric to Poll do not contribute noticeably to Fgf8 expression at this stage of development.
Enhancer Activity versus Gene Expression
Intriguingly, the transgenic screen of individual modules identified several additional elements in the region that drove highly reproducible activities in domains that did not correspond readily to Fgf8. Some of these likely resulted from the increased stability of the LacZ reporter gene: for example, the staining in the posterior somites observed with CE80 ( Figures 1C and S2 ) was most probably due to residual b-gal proteins in cells coming from the presomitic mesoderm where short-lived Fgf8 mRNAs are transcribed (Dubrulle and Pourquié , 2004 ). Yet, this explanation cannot account for many other ''ectopic'' patterns that were observed with other elements, such as in the forebrain (from CE63 or CE64), the heart (CE71), or the posterior limb mesenchyme (CE63). Interestingly, some elements were acting as enhancers both in an Fgf8 expression domain and in an ectopic one, as shown by CE62 (in the optic stalk and in the branchial arch mesoderm, respectively).
These transgenic assays were performed with a neutral but heterologous promoter. To test if the ectopic domains corresponded to this artificial juxtaposition, we repeated this transgenic assay for CE64 and CE71 with the promoter region of Fgf8. We cloned the mouse Fgf8 region extending from À721 to +198 (transcriptional start site is +1) and fused the LacZ coding region at Fgf8 start codon. This fragment included the proximal region highly conserved in mammals and the entire region decorated by promoter-associated histone marks in Fgf8-expressing tissues (Shen et al., 2012) . With CE71, we obtained four independent transgenic embryos, none of them showing reporter gene activity. This result suggests that the Fgf8 promoter may respond less efficiently to CE71 than the b-globin promoter, even though the difference (0/4 versus 3/7) is statistically not very significant. In contrast, CE64-Fgf8::LacZ showed a broad expression pattern in the midbrain-hindbrain, in the forebrain, posterior neural tube, and dorsal ganglia of transgenic embryos, exactly like CE64-bglob::LacZ ( Figure 4A ). From this, we concluded that the promoter of Fgf8 is responsive to at least some of these ectopic activities when put next to these normally remote enhancers. Therefore, mechanisms other than promoter specificity must account for the differences observed between endogenous gene expression and enhancer activity.
To look at these, we used a large human BAC extending from POLL to the 3 0 end of FGF8, containing the enhancers CE49 to CE80 but excluding FGF8 promoter region ( Figure 4B ). This BAC reproduces more accurately the endogenous genomic context and should reveal the collective output produced by the whole region. We inserted the b-globin minimal promoter-LacZ reporter gene independently at six different positions along the BAC and injected each modified and linearized BAC separately. Each BAC with a given insertion showed very reproducible expression patterns between independent transgenic embryos: embryos with higher BAC copy numbers showed moderately stronger LacZ signals, but no additional expression domains ( Figure S4 ). Strikingly, in this assay, most of the ectopic expression domains observed with single-element transgenes were not recapitulated (Figures 4 and S4 ). For example, in the BAC assay, the CE62-dependent expression in the eye was maintained, contrary to the branchial arch mesenchymal expression driven by the same element in the single element assay, even when the reporter gene was inserted only 4 kb away. The broad forebrain and mid-hindbrain expression domains associated with CE63/CE64 and CE54/CE64/CE80, respectively, were drastically reduced in BAC transgenic embryos, matching more closely to the restricted expression of Fgf8 in these domains. The cardiac expression driven by CE71 was only detected locally, when the reporter gene was inserted 7 kb away (insertion III), but not 30 or 54 kb away (flanking insertions II and IV, respectively). Additionally, all BAC transgenes showed robust expression in the branchial arch ectoderm, even though we failed to find any compact module with such an activity, autonomously, in our set of evolutionary conserved noncoding elements.
Altogether, these experiments showed that the regulatory output of this genomic interval is very different from the superposition of the activities of the individual modules that compose it. In the endogenous context, many intrinsic enhancer activities are filtered out, independently of promoter sequences. Noteworthy, the output changed with the position of the reporter gene. The most centromeric insertions showed expression only in few domains (branchial arches, forebrain, tail bud, and AER) and usually with weak intensity. Medial insertions (II and III) were expressed in most Fgf8 domains, but with a weak MHB expression, and they showed additional expression domains, such as the CE71-dependent heart. Insertions IV and V closer to Fgf8 displayed an expression pattern very similar to a Fgf8 LacZ knockin-allele (Ilagan et al., 2006) , lacked the ectopic heart expression seen in III, and had a robust MHB expression, particularly for insertion V. These graded responses to the different modules, according to the position of the reporter used to record them, showed that their activities were not evenly distributed along the locus, in contrast to the wide distribution of the corresponding enhancers. Suggestively, even in absence of Fgf8 promoter, the profile matching the closest to Fgf8 (considering as well the absence of ectopic expression) was obtained at proximity of the normal location of this gene.
Enhancer-to-Gene Specificity Depends on the Structure of the Locus
We reasoned that this uneven distribution of enhancer activities along the locus may also contribute to ensure that the remote enhancers interact preferentially with Fgf8 rather than with genes closer to them. To assess the effects of an altered organization of the locus, we generated transgenic mouse lines by injection of a circular chicken BAC CH261-53D13 extending from Btrc to Mgae5 (Figure 5A ). When injected as circular molecules, BACs are prone to adopt an altered organization, depending on the internal breakpoint used for integration. In transgenic embryos carrying CH261-53D13, we detected expression of the chicken transgenic Fgf8 gene in several Fgf8 domains (MHB, AER, branchial arch ectoderm, forebrain, tail bud), showing that this BAC contained the corresponding regulatory information ( Figure 5B ). Unexpectedly, in two independent lines, we found that the chicken Fbxw4 gene displayed a robust Fgf8-like expression pattern, contrasting with the basal widespread expression of the endogenous gene in murine and chick embryos (Figures 1,  2, 3, 4 , and 5A-5C). It showed that Fbxw4 was competent to respond to Fgf8 enhancers, even in presence of a competing Fgf8 gene, when the structural organization of the locus or its context was changed. Interestingly, in these cases, Fbxw4 responded to the multiple independent modules spread across the region, like Fgf8, and not only to a subset of them.
If the BAC transgenic experiments suggested strongly that the organization of the region contributed to enhancer-to-gene specificity, the exact structure of the integrated BACs cannot be ascertained. Therefore, we produced a series of specific chromosomal rearrangements affecting the structure of the endogenous Poll-Fgf8 locus in a targeted manner. We obtained a balanced inversion that repositioned the Elovl3 gene at the place of Fgf8 by in vivo Cre-mediated recombination between loxP sites inserted in Fgf8 and in the 3 0 end of Pitx3 (Figures 6  and S5 ). In wild-type embryos, Elovl3 was undetectable by RT-qPCR ( Figure 6B ). In embryos heterozygous for the inversion, we found a low but significant expression of Elovl3 in the limb buds. This expression was strongly enriched in the distal part (B) Transgenic embryos carrying the RP11-958B14 BAC showed different LacZ staining depending on the position of the bglob::LacZ reporter gene (insertions 0 to V). The region covered by the BAC (from the 3 0 end of BTRC to FGF8, excluding its promoter) is boxed. For simplicity, only some of the enhancers are represented. Their color corresponds to their activity, as shown on the schematized embryo (blue, MHB; green, eye; red, heart; orange, AER; purple, regulatory potentials detected at short range but never in the context of the BAC transgenes). Colored lines depict the distribution of the corresponding regulatory activities along the region. Additional embryos with BAC copy numbers are shown in Figure S4 .
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Genomic Structure Shapes Gene Expression of the limb (including the AER) compared to the proximal region, suggesting that this exchange of position led Elovl3 to respond to Fgf8 AER enhancers. In these embryos, Btrc, Dpcd, Poll, and Fbxw4 expression levels were unaffected; Lbx1 showed only a slight upregulation in the limb ( Figure 6B ).
We produced two additional configurations, DUP(L-F8) and DUP(L-F4), corresponding to tandem duplications of the region between the 3 0 end of Lbx1 and the 3 0 end of Fgf8, and between the 3 0 end of Lbx1 and the second intron of Fbxw4, respectively ( Figures 6 and S5) . These duplications positioned the entire Lbx1 promoter at the position of Fgf8 or in the intron of Fbxw4. In both cases, the coding sequence of this copy of Lbx1 was replaced by GFP, allowing direct monitoring of the activity of the relocated Lbx1 promoter. We collected E10.5 embryos heterozygous for one or the other configuration. In DUP(L-F8) embryos, GFP was expressed in all typical Fgf8 domains, including forebrain and MHB, branchial arches, AER, and tail bud ( Figure 6C) . The smaller duplication, where Lbx1 promoter is not at the Fgf8 position but in the second intron of Fbxw4, also led to GFP expression in the AER, however, with a much weaker intensity. The same reduction was seen in the forebrain and BA ectoderm, whereas other domains (tail bud, MHB) were hardly visible ( Figure 6C) . These experiments demonstrated that Lbx1 promoter can respond to the different Fgf8 enhancers, yet much more efficiently when positioned at the normal location of Fgf8. Altogether, these data showed that upon structural reshuffling of the locus the output of the Fgf8regulatory region was transferred in a coherent manner with respect to its tissue-specificity to the gene now located at Fgf8 position.
DISCUSSION

An Intricate Regulatory Landscape
Despite the localization of Fgf8 in a gene-dense region, its regulatory domain is not smaller than ones described for other genes (Carvajal et al., 2001; Jeong et al., 2006; Kleinjan et al., 2006; Montavon et al., 2011) . Indeed, many enhancers that regulate Fgf8 are more than 90 kb away from its promoter, closer to other genes, and interspersed with Fbxw4 exons. The large number of enhancers with overlapping tissue-specific activities is particularly striking, as illustrated by the multiple regulatory elements active in the limb AER. Importantly, the proximal enhancers are not sufficient to initiate or maintain Fgf8 expression when the (B and C) In situ hybridization with chicken Fgf8 and Fbxw4 probes of E10.5 mouse embryos transgenic for a circular-injected BAC (two independent lines c53D13-A and -E), wild-type controls (WT, E10.5 mouse and stage 24 chick embryos). The chicken mRNA probes did not cross-hybridize with mouse genes, and revealed that cFbxw4 adopted an Fgf8-like expression in CH261-53D13 transgenic embryos. (D) Close-up apical view of mutant and WT forelimb buds shows presence/absence of the signal in the AER. AER, apical ectodermal ridge; BA, first branchial arch ectoderm; CP, forebrain commissural plate; MHB, midbrain-hindbrain boundary; SO, somites; TB, tail bud. more distal ones with the same activity are deleted. Thus, these elements are not simple redundant ''shadow enhancers'' that buffer gene expression against genetic or environmental variations (Hong et al., 2008; Frankel et al., 2010; Perry et al., 2010) .
Integration and Interdependence of Regulatory Modules
This functional interdependence between Fgf8 regulatory elements in the endogenous context contrasts with their functional autonomy in transgenic assays. However, we noticed that in single element transgenic assays, the different AER enhancers were quite sensitive to position effects: only half of the insertions showed expression, and some exhibited mosaic LacZ staining ( Figure S2 ). In contrast, BAC transgenes with the full complement of AER modules showed robust and very penetrant AER expression, suggesting some kind of synergy.
Several mechanisms may account for this interdependence and operational synergy. Different enhancers may fulfill distinct roles in the context of highly interconnected gene regulatory networks, and the absence of some of them may lead to a collapse of networks where Fgf8 has a central role, such as in the MHB (reviewed in Sato et al., 2004) . In this tissue, CE64 may initiate early expression of Fgf8, and CE79 may maintain Fgf8 expression in response to Pax2 (Inoue et al., 2008) . The AER, in contrast, is not dramatically affected by the absence of Fgf8, and the impact on downstream gene expression is minimal (Lewandoski et al., 2000) : in this case, we suggest that the synergy between the proximal and distal AER enhancers may reflect direct functional interactions in cis.
Integration and Filtering: Activity versus Function
Strikingly, this region comprises a surprisingly high number of elements whose enhancer activities are not obviously related to endogenous gene expression, in contrast to previous equivalent studies of large regions where most elements could be
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Genomic Structure Shapes Gene Expression associated with neighboring gene expression (Carvajal et al., 2001; Uchikawa et al., 2003; Kleinjan et al., 2006; Gonzalez et al., 2007) . These elements are operational ''enhancers'' (as defined by an in vivo transgenic assay) and some harbor chromatin marks characteristic of enhancers in vivo: CE71 is bound by p300 in E11.5 embryonic heart (Blow et al., 2010) , and CE63 is enriched for H3K27Ac in E11.5 limbs (Cotney et al., 2012) . These elements can act on a range of promoters, including Fgf8, suggesting that promoter-defined local chromatin environment may not be sufficient to protect genes from their influence. Nevertheless, a large part of the activities of the individual modules appears to be operationally filtered out in the endogenous context. There is therefore an important gap between the intrinsic regulatory potential of an enhancer (the activity it can display when randomly inserted in the genome, reflecting the properties of its sequence and of the transcription factors that bind to it) and its regulatory function (its contribution to gene expression in its normal genomic position) that can be much more restricted ( Figure 7A ). The BAC assays suggest that these intrinsic regulatory potentials are displayed at short distances: only some of them are active over larger distances and are therefore able to reach potential target genes. Gene promoters play only a minor role in this integration/filtering process, whereas the genomic positions of the potential target genes seem to be a more critical factor.
Holistic Control of Gene Expression
Interestingly, we noticed that Fgf8 expression domains were often associated with multiple enhancers, whereas the ectopic enhancer activities found in the region were usually represented by a single module. This observation suggests that cis-interactions between the different modules with overlapping activities may reinforce the frequency of their association with the target gene, up to their coalescence with bound transcription factors into a large enhancing complex over the Fgf8 promoter (Figure 7B) . As shown for the Sonic hedgehog gene, remote enhancer-promoter interactions may be infrequent and lead to sporadic gene expression at the cellular level (Amano et al., 2009; Noordermeer et al., 2011) . Multiple AER enhancers can synergize through direct interactions or simply increase the chance that the Fgf8 promoter would be in contact with any one of them, to compensate for the possible paucity of pairwise interactions mediated by single remote elements. In contrast, the ectopic activities associated with single modules may not yield productive transcription on remote target promoters due to weak or infrequent interactions.
Interactions between multiple enhancers may lead the region to adopt a defined structural conformation that could favor regulatory interactions between enhancers and specific positions of the locus instead of with specific promoter sequences. This is what suggests the uneven distribution of enhancer activities on the BAC transgenes and the general tropism for the position normally occupied by Fgf8. Even though it is possible to deconstruct it into autonomous modules, the whole region seems to work as a coherent integrated regulatory ensemble, which overall activity cannot simply be determined by the addition of its basal components. The importance of the genomic context in shaping both the tissue-and the target-specificity of this region The Fgf8 gene-dense region comprises multiple enhancers (ovals) distributed within introns of the bystander genes (gray rectangles). Enhancers are color-coded to match the expression domains depicted on the mouse embryo outlines. (A) Although individual enhancers possess large and diverse intrinsic autonomous activities (upper embryo), their collective output is not equal to their superposition: only a subset of these activities is displayed over distance to endogenous genes and polarized to the genomic position normally occupied by Fgf8 (lower-right embryo). (B-G) A network of regulatory interactions between several modules with overlapping activities organizes this complex region in a coherent regulatory unit. Different genomic or cellular situations are shown. Enhancer status is indicated (filled, active; stroke-only, inactive) and a halo represents their range of action. Transcriptionally active genes are represented with arrows. (B) In Fgf8-expressing cells (e.g., AER), multiple modules with overlapping activities synergize to extent their range of action, either by dynamic one-to-one interactions (left) or by formation of a meta-enhancer through coalescence of the different modules (right). (C) Other modules (red), active in different cell types, may have only short-range activities and therefore minimal influence on the surrounding genes. Gene position relative to Fgf8 normal position determines the responsiveness to these regulatory elements. Rearrangements have distinct effects, depending on their nature: ectopic action on a new gene (D and E); loss of expression (F); and unmasking of a latent regulatory potential (G). These situations can correspond to conditions found in SHFM3 patients. leads us to define it as a holo-enhancer. In this model, dynamic interactions between the different active elements, involving eventually additional interspersed structural elements, will determine where the regulatory influences are exerted: hence, the output of the entire region would reside in the relative distribution of genes and enhancers along the locus (Figure 7) .
Additional levels of regulation such as the epigenetic status of the promoters could further contribute to shape the genespecific response to these inputs. Indeed, Fgf8 is often covered with the repressive mark H3K27me3 in nonexpressing tissues and cell types (Shen et al., 2012) . Yet, the transgenic assay showed that the Fgf8 promoter region does not carry itself the information that can lead to its epigenetic repression in all the tissues in which we detected ectopic regulatory activities. Furthermore, the BAC assays and the duplications relocating Lbx1 showed that the filtering process operated on multiple and diverse promoters, suggesting further that the regulatory output of the region is mostly promoter-independent. It implies that keeping promoters away from the elements with intrinsic ectopic activities is essential to avoid gene misexpression.
Previous studies have highlighted the role of powerful locuswide acting regulatory elements such as the b-globin locus control region (Palstra et al., 2008) or the Hox global control region and regulatory archipelago (Spitz et al., 2003; Montavon et al., 2011) . These elements may be well adapted to genedeserts or extended gene clusters, but they can constitute regulatory challenges in intricate regions comprising multiple genes that need to be regulated independently. One could imagine that batteries of enhancer-blocker elements and silencers may in theory achieve the specificity observed in the Fgf8 locus. But these elements would need to have additional properties (short range of action, enhancer-specificity) to avoid pleiotropic effects on the surrounding active genes. Several CTCF binding sites have been identified along the region (Shen et al., 2012) . However, given their interlaced distribution between the enhancers and the different target genes, their contribution would be very different from the strict enhancer-blocker usually envisioned. As CTCF, cohesin and mediator proteins are ubiquitously expressed, it is unclear how they could organize cell-typespecific interactions (Hou et al., 2010) . The consequences of the engineered rearrangements at the Fgf8 locus further suggest that there is no recognition code between pairs of CTCF sites to direct enhancers toward a specific target gene. Instead, dynamic interactions between the multiple modules active in a tissue and target gene(s) may bring transiently specific CTCF sites in close proximity, enabling eventually CTCF-cohesin complexes to in turn stabilize these active conformations. In this way, the system used at the Fgf8 locus may be very appropriate for a gene-dense region: the interdependency of the short range-modules and the resulting positional tropism of the regulatory region would ensure both specificity and precision and limit the collateral effects that characterize other systems (Montavon et al., 2008) .
Evolutionary Implications
The extended and interlaced structure of the Fgf8 regulatory landscape with other genes may have acted as a strong pressure to preserve its synteny. Indeed, the Fbxw4-Fgf8 association has been maintained in both chordates and hemichordates (Cañ es-tro et al., 2007) . Interestingly, in teleost fishes, one of the duplicated Fgf8 loci retained the original genomic structure, keeping Fbxw4 as well as the intragenic and intergenic conserved elements/enhancers, whereas the other copy lost most of the ancestral elements. This unequal partition further suggests that this large regulatory region functions as a whole unit. As noted previously, the existence of multiple enhancers with overlapping activities can confer robustness, as proposed for shadow enhancers. It constitutes a flexible system where modifications of individual elements can modulate Fgf8 expression and limb morphologies. Remarkably, the functional interdependence of the different modules can act as a pressure to maintain such a situation, favorable for evolutionary experimentation. The presence of additional regulatory activities embedded in the holo-enhancer may also facilitate the acquisition of new expression domains, for example by unmasking a latent activity already present, without a need for evolving new enhancers. These latent regulatory potentials may be a by-product of the regulatory code associated with a role of these modules in a different tissue or at a later stage. As enhancers seem constrained in keeping their regulatory syntax (Brown et al., 2007) , silencing or filtering these additional associated activities out may be evolutionary simpler than evolving a more specific module.
Holo-Enhancers, Human Genomic Disorders, and Structural Variations
Our findings provide also a conceptual framework to understand the consequences of genomic changes affecting this region. In humans, duplications of the region lead to split hand/split foot malformation type 3 (SHFM3), a condition characterized by limbs missing the central digits, associated in some patients with micrognathia and hearing disorders (de Mollerat et al., 2003; Dimitrov et al., 2010) . These duplications disrupt the organization of the region, which may lead to misexpression of one or multiple genes; their nature and new ectopic patterns may vary, depending on the breakpoints, similarly to what we observed with a GFP-tagged Lbx1 gene in mice carrying corresponding duplications. Hence, if holo-enhancers build their specific output from sparse elements with widespread activities by using genomic structure and distance to filter them, they may be quite sensitive to structural alterations (Figure 7) . The SHFM3-like condition in Dactylaplasia mice due to insertions of retroelements within the holo-enhancer region (Sidow et al., 1999; Friedli et al., 2008) further emphasizes the sensitivity of this system toward what could appear as relatively mild genomic changes. Likewise, structural variations found in humans (Stankiewicz and Lupski, 2010) could lead to phenotypic diversity not only by altering specific elements, but also by modifying an underlying organization that controls how multiple regulatory inputs present within a locus are transformed into specific gene expression activities.
EXPERIMENTAL PROCEDURES
Transgenic Analyses
Each CNE enhancer candidate was cloned upstream of a LacZ reporter gene (blac) driven by a b-globin-derived minimal promoter (detailed in Supplemental Experimental Procedures). Gel-purified linear fragments were microinjected into fertilized mouse oocytes and transferred to pseudo-pregnant females (EMBL Transgenic Service; Cyagen Biosciences Guangzhou). Founder embryos were collected at E10.5, stained for b-galactosidase activity, and genotyped by PCR on yolk sack DNA.
Human RP11-958B14 and chicken CH261-53D13 BACs were obtained from CHORI. RP11-958B14 was targeted with a blac reporter gene by ET-recombineering (see Supplemental Experimental Procedures), except insertion 0, which was produced by Tn7-mediated transposition (Spitz et al., 2003) . RP11-958B14 derivatives were linearized with PI-SceI, whereas CH261-53D13 was injected as a circular molecule. Otherwise, BAC DNA were purified and microinjected as described previously (Zuniga et al., 2004) . Transgenic embryos were genotyped by PCR. For RP11-958B14, we verified the presence of 16 specific landmarks using human-specific primers and only embryos carrying an entire BAC construct were considered for further analysis; most of these carried from one to two copies of the BAC with few having five or seven copies (see Supplemental Experimental Procedures for details).
Mouse Strains with Targeted Rearrangements
The inversion INV(F8-P3) was generated by STRING (Spitz et al., 2005) , using strains with loxP sites in the Fgf8 gene (F8) (Meyers et al., 1998) , the 3 0 UTR of Pitx3 (P3) (Zhao et al., 2004) , and an Hprt-Cre driver (Tang et al., 2002) . Other alleles were produced by targeted meiotic recombination (TAMERE) (Hé rault et al., 1998) , using strains with the following loxP sites: F8 in Fgf8, Lbx1::GFP (L) (Vasyutina et al., 2005) , and Poll (P) (Bertocci et al., 2002) . The loxP site in Fbxw4 (F4) was introduced by homologous recombination in ES cells (see Supplemental Experimental Procedures). The different strains were genotyped by PCR.
X-Gal Staining, GFP Imaging, In Situ Hybridizations, and Skeletal Preparation b-galactosidase staining and whole-mount in situ hybridization were performed according to standard protocols. In situ probes included mouse and chicken Fgf8 (Crossley and Martin, 1995; Crossley et al., 1996) , murine probes for Btrc, Poll, Dpcd, Fbxw4, and the probe for chick Fbxw4 were subcloned from EST clones (IRAKp961-O218, -G216, -I1567, -F0653, and chick EST 441j4, respectively), and mouse Lbx1 and Elovl3 probes were amplified by PCR (Supplemental Experimental Procedures) from cDNAs from embryonic tissues, subcloned and sequenced. GFP expression was assessed with a Leica MZ16F fluorescent stereomicroscope and a Zeiss LSM780 laser-scanning microscope. Skeletons of E18.5 mouse embryos were prepared and stained with standard Alcian blue/Alizarin red protocols.
Mouse experiments were conducted in accordance with the principles and guidelines in place at European Molecular Biology Laboratory, as defined and overseen by its Institutional Animal Care and Use Committee, in accordance with the European Directive 2010/63/EU.
Quantitative RT-PCR
Total RNA was purified from tissues dissected from E10.5 embryos. Detailed protocol and primers are listed in the Supplemental Experimental Procedures. Gene expression was normalized to multiple controls (Actb, Pgk1, and Tbp genes), using the 7500 software V2.0.5 (Applied Biosystems). Each sample corresponded to tissues pooled from three to four embryos. Two to three biological replicates were used for each condition and each measurement was made in duplicate.
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